NextPlat Reports Consolidated Third Quarter 2023 Results with Increased Revenues of $15.3 Million, Margins Improve to 30% and $2.7 Million Net Income

Rhea-AI Summary

NextPlat Corp (NASDAQ: NXPL, NXPLW) reports double-digit growth in both healthcare and e-commerce operations, with consolidated revenues of $15.3 million in Q3 2023. Gross margins increased to 30%, and net income was approximately $2.6 million. The company ended the quarter with $26.3 million in cash. The PR highlights the company's financial performance, strategic acquisitions, and expansion into the Chinese market through Alibaba's Tmall Global platform.

Positive

• Consolidated revenues increased by over 481% compared to Q3 2022.
• Gross margins improved to 30% in Q3 2023.
• Net income was approximately $2.6 million, compared to a net loss of $5.7 million in Q3 2022.
• The company ended the quarter with approximately $26.3 million in cash.
• Strategic acquisition of a controlling interest in Progressive Care, Inc., and expansion into the Chinese market through Alibaba's Tmall Global platform present significant growth opportunities.

Negative

• None.

Company Sees Double-Digit Growth at Both its Healthcare and e-Commerce Operations; Balance Sheet Features $26.3 Million in Cash to Help Accelerate Growth

COCONUT GROVE, Fla., Nov. 14, 2023 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced the financial results for the three months ended September 30, 2023 which consolidates the operations of its e-commerce business with the results of its healthcare operations, Progressive Care, Inc. (OTCQB: RXMD) ("Progressive Care").

"The third quarter of 2023 marks an inflection point for NextPlat as we report the consolidation of our global e-commerce and Progressive Care healthcare operations. As a unified business, our teams are focused on maximizing the value of each of its operations through the launch of new online storefronts for customers including OPKO Health into China's multi-billion dollar marketplace on Alibaba's Tmall Global, and the further expansion of Progressive Care's services for both patients and providers," said Charles M. Fernandez, Executive Chairman and CEO of NextPlat Corp. "The intersection of technology, global e-commerce, and healthcare, creates tremendous opportunities for NextPlat. Our continued growth is supported by strong, debt-free balance sheets with sufficient cash to invest both internally and in acquisitions that can quickly add scale to our platform. It is through these investments that we intent to create greater synergies in our business as we seek to unlock valuable new benefits for our customers, partners, patients, and shareholders."

Third Quarter 2023 Financial Highlights:

• Consolidated revenues for the third quarter were approximately $15.3 million, an increase of over 481% versus revenue of approximately $2.6 million in the third quarter of 2022. Our third quarter 2022 revenues only reflect the results of the Company's e-commerce operations. e-Commerce revenues were approximately $2.9 million, reflecting growth of 11% when compared to its reported revenues in the third quarter of 2022. The contribution of the Company's healthcare operations were approximately $12.4 million for the third quarter of 2023 and is a result of the Progressive Care consolidation as of July 1, 2023.
• Gross margins increased significantly to 30% for the quarter ended September 30, 2023, up from 26% reported for the quarter ended September 30, 2022, primarily attributable to the healthcare operations because of the Progressive Care consolidation. Gross profit margin attributable to our healthcare operations were approximately 31%. Our e-commerce profit margins improved to over 27% from under 26% reported in the third quarter of 2022.
• Operating expenses for the quarter ended September 30, 2023, were approximately $8.1 million, an increase of approximately $5.2 million compared to approximately $2.8 million in the year-ago period. The increase was primarily driven by expenses including stock-based compensation of approximately $1.2 million (non-cash expense), salaries and wages of approximately $1.8 million, amortization expense of approximately $0.7 million, and net other operating expense of approximately $1.5 million.
• Net income for the quarter ended September 30, 2023, was approximately $2.6 million, or $0.17 diluted earnings per share compared to a net loss of approximately $5.7 million, or $0.60 diluted earnings per share reported for the quarter ended September 30, 2022. Net income in the third quarter of 2023 includes a one-time, gain on equity method investment of approximately $6.1 million (non-cash expense) related to the change in accounting method due to the Progressive Care consolidation as of July 1, 2023. The net loss in 2022 includes an equity in net loss of affiliate expense of approximately $3.4 million (non-cash expense) for its strategic investment in Progressive Care prior to the consolidation on July 1, 2023.
• The Company ended the third quarter of 2023 with approximately $26.3 million in cash.

Organizational Highlights and Recent Business Developments:

• Effective on July 1, 2023, NextPlat, together with its Executive Chairman and CEO, Charles M. Fernandez, and its Director, Rodney Barreto, acquired a controlling interest in Progressive Care, Inc. As such, Progressive Care is now a consolidated subsidiary of the Company for accounting purposes. The Company intends to support Progressive Care's continued rapid growth through a series of business development and expansion activities designed to boost the continued expansion of Progressive Care's healthcare offerings.
• NextPlat announced its first customer for its Florida e-commerce development program, agreeing to exclusively launch the online sales of OPKO Healthcare ("OPKO") products in China on Alibaba's Tmall Global platform. OPKO is a global diversified diagnostic and pharmaceutical healthcare company with over 5,500 employees spanning nine countries. Through this new e-commerce agreement, NextPlat will develop and launch an OPKO-branded storefront on Tmall Global and offer select nutraceutical and veterinary products for sale to potentially millions of Chinese consumers starting in the first quarter of 2024.
• The Company is also currently developing a full-line of premium-grade vitamins and dietary supplements under the Florida Sunshine brand name which it can sell to domestic and international markets, including China via the Tmall Global platform.

David Phipps, President of NextPlat and CEO of Global Operations, added, "Supported by the reach of our global platform and network of key partners, we see an increasing number of opportunities to leverage our capabilities to assist businesses across multiple high-growth domestic and international markets, to grow their online presence and e-commerce revenue. Our unique expertise and access into large markets such as China through Alibaba's Tmall Global, positions us well to penetrate several additional consumer and commercial sectors with a broad array of products and high-value services starting in 2024."

The financial information included in this press release should be read in conjunction with the Company's Form 10-Q report for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission.

For more information regarding the financial results of Progressive Care Inc. for the quarter ended September 30, 2023, investors should refer to its Form 10-Q as filed with the Securities and Exchange Commission.

About NextPlat Corp
NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the Company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide and pharmacy and healthcare data management services in the United States.

Forward-Looking Statements
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce capabilities for physical and digital assets, transact business in crypto currencies and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

Media and Investor Contact for NextPlat Corp:
Michael Glickman
MWGCO, Inc.
917-397-2272
mike@mwgco.net

NEXTPLAT CORP AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
		Three Months Ended				Three Months Ended				Nine Months Ended				Nine Months Ended
		September 30, 2023				September 30, 2022				September 30, 2023				September 30, 2022
		(Unaudited)				(Unaudited)				(Unaudited)				(Unaudited)
Sales of products, net		$	12,788,758			$	2,630,826			$	18,622,274			$	9,080,083
Revenues from services			2,501,413				-				2,501,413				-
Revenue, net			15,290,171				2,630,826				21,123,687				9,080,083
Cost of products			10,633,953				1,952,072				15,002,783				7,032,847
Cost of services			71,536				-				71,536				-
Cost of revenue			10,705,489				1,952,072				15,074,319				7,032,847
Gross profit			4,584,682				678,754				6,049,368				2,047,236
Operating expenses:
Selling, general and administrative			4,187,429				1,699,711				7,495,601				3,434,916
Salaries, wages and payroll taxes			2,483,432				651,219				4,039,307				1,957,592
Professional fees			520,726				356,306				1,385,474				839,509
Depreciation and amortization			871,066				136,457				1,200,825				348,022
Total operating expenses			8,062,653				2,843,693				14,121,207				6,580,039
Loss before other (income) expense			(3,477,971)				(2,164,939)				(8,071,839)				(4,532,803)
Other (income) expense:
Interest expense			45,949				8,725				55,657				15,649
Interest earned			(209,798)				(3,849)				(392,545)				(13,421)
Other income			-				-				(315,845)				-
Foreign currency exchange rate variance			164,504				89,025				95,831				229,753
Total other (income) expense			655				93,901				(556,902)				231,981
Loss before income taxes and equity in net loss of affiliate			(3,478,626)				(2,258,840)				(7,514,937)				(4,764,784)
Income taxes			(23,011)				-				(75,034)				-
Loss before equity in net loss of affiliate			(3,501,637)				(2,258,840)				(7,589,971)				(4,764,784)
Gain on remeasurement of fair value of equity interest in affiliate prior to acquisition			6,138,051				-				6,138,051				-
Equity in net loss of affiliate			-				(3,454,436)				(1,439,637)				(3,454,436)
Net income (loss)			2,636,414				(5,713,276)				(2,891,557)				(8,219,220)
Net loss attributable to noncontrolling interest			811,239				-				811,239				-
Net income (loss) attributable to NextPlat Corp		$	3,447,653			$	(5,713,276)			$	(2,080,318)			$	(8,219,220)
Comprehensive income (loss):
Net income (loss)		$	2,636,414			$	(5,713,276)			$	(2,891,557)			$	(8,219,220)
Foreign currency gain (loss)			18,801				(67,635)				(16,152)				(87,753)
Comprehensive income (loss)		$	2,655,215			$	(5,780,911)			$	(2,907,709)			$	(8,306,973)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS		$	3,447,653			$	(5,713,276)			$	(2,080,318)			$	(8,219,220)
Weighted number of common shares outstanding – basic			18,702,857				9,469,509				17,079,077				9,310,936
Weighted number of common shares outstanding – diluted			20,295,549				9,469,509				17,079,077				9,310,936
Basic earnings (loss) per share		$	0.18			$	(0.60)			$	(0.12)			$	(0.88)
Diluted earnings (loss) per share		$	0.17			$	(0.60)			$	(0.12)			$	(0.88)

 

NEXTPLAT CORP AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS
		September 30, 2023				December 31, 2022
		(Unaudited)				(Audited)
ASSETS
Current Assets
Cash		$	26,345,704			$	18,891,232
Accounts receivable, net			7,802,121				383,786
Receivables - other, net			2,945,327				-
Inventory, net			4,986,734				1,286,612
Unbilled revenue			168,678				141,702
VAT receivable			369,422				432,769
Prepaid expenses			865,766				45,679
Notes receivable			251,485				-
Total Current Assets			43,735,237				21,181,780
Property and equipment, net			4,046,854				1,245,802
Goodwill			3,144,000				-
Intangible assets, net			14,116,748				50,001
Operating right of use assets, net			1,035,269				854,862
Finance right-of-use assets, net			28,807				-
Equity method investment			-				5,260,525
Deposits			39,137				-
Prepaid expenses, net of current portion			49,135				49,078
Total Other Assets			18,413,096				6,214,466
Total Assets		$	66,195,187			$	28,642,048
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses		$	13,680,665			$	1,518,095
Contract liabilities			29,223				36,415
Notes payable			385,303				60,490
Due to related party			25,001				28,467
Operating lease liabilities			366,494				208,660
Finance lease liabilities			20,691				-
Income taxes payable			178,310				94,244
Liabilities from discontinued operations			-				112,397
Total Current Liabilities			14,685,687				2,058,768
Long Term Liabilities:
Notes payable, net of current portion			1,251,159				156,266
Operating lease liabilities, net of current portion			712,521				649,895
Finance lease liabilities, net of current portion			9,897				-
Total Liabilities			16,659,264				2,864,929
Commitments and Contingencies			-				-
Equity
Preferred stock ($0.0001 par value; 3,333,333 shares authorized)			-				-
Common stock ($0.0001 par value; 50,000,000 shares authorized, 18,724,596 and 14,402,025 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively)			1,872				1,440
Additional paid-in capital			66,469,956				56,963,200
Accumulated deficit			(33,227,122)				(31,146,804)
Accumulated other comprehensive loss			(56,869)				(40,717)
Equity attributable to NextPlat Corp stockholders			33,187,837				25,777,119
Equity attributable to noncontrolling interests			16,348,086				-
Total Equity			49,535,923				25,777,119
Total Liabilities and Equity		$	66,195,187			$	28,642,048

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplat-reports-consolidated-third-quarter-2023-results-with-increased-revenues-of-15-3-million-margins-improve-to-30-and-2-7-million-net-income-301986948.html

SOURCE NextPlat Corp.

FAQ

What were NextPlat Corp's consolidated revenues in Q3 2023?

NextPlat Corp's consolidated revenues for Q3 2023 were approximately $15.3 million, reflecting an increase of over 481% compared to Q3 2022.

What was the net income for NextPlat Corp in Q3 2023?

NextPlat Corp reported a net income of approximately $2.6 million in Q3 2023, compared to a net loss of $5.7 million in Q3 2022.

How much cash did NextPlat Corp have at the end of Q3 2023?

NextPlat Corp ended Q3 2023 with approximately $26.3 million in cash.

What strategic developments did NextPlat Corp announce for its e-commerce operations?

NextPlat Corp announced the exclusive launch of OPKO Healthcare products in China on Alibaba's Tmall Global platform, as well as the development of a full line of premium-grade vitamins and dietary supplements under the Florida Sunshine brand name for domestic and international markets.

What was the impact of the acquisition of a controlling interest in Progressive Care, Inc. on NextPlat Corp's operations?

The acquisition of a controlling interest in Progressive Care, Inc. has led to the consolidation of Progressive Care as a subsidiary of NextPlat, presenting opportunities for the continued rapid growth and expansion of Progressive Care's healthcare offerings.